AstraZeneca AZD0530 (saracatinib) Mechanism of Action

First Page		Document Content
Date: 2015-02-11 13:23:13 Tyrosine kinase Prostate cancer Tyrosine kinase inhibitors Organochlorides Benzamides Amines Crenolanib Apatinib Organic chemistry Chemistry Organofluorides		AstraZeneca AZD0530 (saracatinib) Mechanism of Action Add to Reading List Source URL: www.ncats.nih.gov Download Document from Source Website File Size: 64,87 KB Share Document on Facebook

	Diagnostic Assay for Gastrointestinal stromal tumors (GIST) Background GIST can occur anywhere along the GI tract, but most often are found in the stomach or small intestine. Patients with GIST are treated by surgery and DocID: 19Lqh - View Document
	AstraZeneca AZD0530 (saracatinib) Mechanism of Action DocID: 10ZqQ - View Document
	PRELIMINARY REPORT OF CRENOLANIB IN THE TREATMENT OF ADVANCED PLATELET DERIVED GROWTH FACTOR A (PDGFRA) D842V MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST) 1 Mehren , 2 DocID: 10xcR - View Document
	NCI Protocol #: PBTC-042 Local Protocol #: PBTC-042 Version date: 03 July 2014 Protocol Abstract and Schema PBTC-042: Phase I study of CDK 4-6 inhibitor PD[removed]in children with recurrent, DocID: JbpT - View Document
	Translational Medicine and New Therapies for the Treatment of GIST Brian Rubin, MD, PhD Anatomic Pathology and Molecular Genetics DocID: 76sB - View Document